Q: How do different sleep stages (REM vs non‑REM) affect ventricular myocardial excitability and capture thresholds in LP recipients, and is there a reproducible pattern across patients?

Short answer: Non‑REM (NREM) sleep is characterized by higher parasympathetic (vagal) tone and lower myocardial temperature/metabolic demand, conditions that can slightly increase the minimum energy needed for reliable capture in some patients. REM sleep features phasic sympathetic bursts and irregular respiration that can transiently lower or fluctuate thresholds. While a population‑level trend (higher thresholds in NREM vs more variable thresholds in REM) is plausible, individual patterns vary with device settings, autonomic reactivity, and lead–myocardium interface biology.

Physiologic basis by sleep stage

Non‑REM (N1–N3)

Predominant vagal tone → slowed conduction, longer refractoriness, reduced excitability.
Slightly lower core/skin temperature at night may raise capture thresholds modestly.
Stable breathing and intrathoracic pressures; less variability but potentially higher average threshold.

REM

Phasic sympathetic surges → increased excitability; thresholds may transiently drop or swing.
Irregular respiration and intrathoracic pressure oscillations can perturb sensing/capture dynamics.
Greater beat‑to‑beat variability; occasional pseudofusion/fusion patterns depending on intrinsic rate.

Is there a reproducible pattern?

Expected group signal: modestly higher thresholds during consolidated NREM periods; more variability during REM.
Inter‑patient variability: magnitude and direction can differ due to encapsulation/impedance trends, myocardial substrate, hydration/electrolytes, and medications (e.g., beta‑blockers).
Device factors: sensing vectors, output safety margins, and any automatic threshold algorithms may mask or exaggerate stage effects.

How to measure it rigorously

Study design

Prospective cohort of single‑chamber LP recipients with time‑locked auto/manual threshold tests during sleep lab polysomnography (1–2 nights) and at home with actigraphy (7–14 nights).
Collect concurrent HRV (RMSSD, HF power), skin temperature, posture, and respiration/SpO₂.

Primary endpoints

Mean threshold difference: NREM vs REM (within‑subject).
Variance measures and phasic changes around REM onsets/offsets.
Cosinor analysis of 24‑h rhythm and mixed‑effects modeling with sleep‑stage covariates.

Exploratory signals

Association of threshold changes with symptoms/arousals or nocturnal non‑capture/pseudofusion events.
Battery impact modeling of any stage‑aware output adjustments.

Clinical/programming implications

If NREM‑elevated thresholds are reproducible, consider night‑aware safety margins or scheduling automatic threshold tests during typical NREM windows (subject to device capabilities).
Keep adjustments asymmetric (higher output at night, revert by day) to preserve battery longevity.
Address modifiable contributors: hydration, electrolyte balance, medication timing, sleep‑disordered breathing.

Important: Apply within model‑specific approved programming options and clinical judgment.